chr6-45422996-G-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001024630.4(RUNX2):c.423+39G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000565 in 1,591,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.000013   (  0   hom.,  cov: 31) 
 Exomes 𝑓:  0.0000049   (  0   hom.  ) 
Consequence
 RUNX2
NM_001024630.4 intron
NM_001024630.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.45  
Publications
1 publications found 
Genes affected
 RUNX2  (HGNC:10472):  (RUNX family transcription factor 2) This gene is a member of the RUNX family of transcription factors and encodes a nuclear protein with an Runt DNA-binding domain. This protein is essential for osteoblastic differentiation and skeletal morphogenesis and acts as a scaffold for nucleic acids and regulatory factors involved in skeletal gene expression. The protein can bind DNA both as a monomer or, with more affinity, as a subunit of a heterodimeric complex. Two regions of potential trinucleotide repeat expansions are present in the N-terminal region of the encoded protein, and these and other mutations in this gene have been associated with the bone development disorder cleidocranial dysplasia (CCD). Transcript variants that encode different protein isoforms result from the use of alternate promoters as well as alternate splicing. [provided by RefSeq, Jul 2016] 
RUNX2 Gene-Disease associations (from GenCC):
- cleidocranial dysplasia 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64). 
BS2
High AC in GnomAdExome4 at 7 AD gene. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| RUNX2 | NM_001024630.4 | c.423+39G>T | intron_variant | Intron 3 of 8 | ENST00000647337.2 | NP_001019801.3 | ||
| RUNX2 | NM_001369405.1 | c.381+39G>T | intron_variant | Intron 1 of 6 | NP_001356334.1 | |||
| RUNX2 | NM_001015051.4 | c.423+39G>T | intron_variant | Intron 3 of 7 | NP_001015051.3 | |||
| RUNX2 | NM_001278478.2 | c.381+39G>T | intron_variant | Intron 1 of 5 | NP_001265407.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000132  AC: 2AN: 151822Hom.:  0  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2
AN: 
151822
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00  AC: 0AN: 210156 AF XY:  0.00   
GnomAD2 exomes 
 AF: 
AC: 
0
AN: 
210156
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00000486  AC: 7AN: 1440116Hom.:  0  Cov.: 35 AF XY:  0.00000140  AC XY: 1AN XY: 716122 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
7
AN: 
1440116
Hom.: 
Cov.: 
35
 AF XY: 
AC XY: 
1
AN XY: 
716122
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
32986
American (AMR) 
 AF: 
AC: 
0
AN: 
43532
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
25706
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
38808
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
84992
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
45962
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
4158
European-Non Finnish (NFE) 
 AF: 
AC: 
7
AN: 
1104532
Other (OTH) 
 AF: 
AC: 
0
AN: 
59440
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.454 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000132  AC: 2AN: 151822Hom.:  0  Cov.: 31 AF XY:  0.00  AC XY: 0AN XY: 74102 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
2
AN: 
151822
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
0
AN XY: 
74102
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41362
American (AMR) 
 AF: 
AC: 
0
AN: 
15276
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5102
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4816
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10580
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
314
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
67904
Other (OTH) 
 AF: 
AC: 
0
AN: 
2088
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.450 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.